Volume | 77,986 |
|
|||||
News | - | ||||||
Day High | 0.939899 | Low High |
|||||
Day Low | 0.8188 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Better Therapeutics Inc | BTTX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.8523 | 0.8188 | 0.939899 | 0.8206 | 0.891 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
149 | 77,986 | $ 0.8436937 | $ 65,796 | - | 0.8188 - 3.23 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:20:08 | formt | 100 | $ 0.8616 | USD |
Better Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 20.34M | 23.61M | 9.59M | $ - | $ - | -3.11 | -0.70 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | 55.00k | 1.80% |
Better Therapeutics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTTX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.02 | 1.11 | 0.8188 | 0.9303635 | 67,239 | -0.1584 | -15.53% |
1 Month | 1.22 | 1.22 | 0.8188 | 1.01 | 35,452 | -0.3584 | -29.38% |
3 Months | 1.13 | 1.50 | 0.8188 | 1.16 | 27,594 | -0.2684 | -23.75% |
6 Months | 1.74 | 1.86 | 0.8188 | 1.37 | 35,058 | -0.8784 | -50.48% |
1 Year | 2.23 | 3.23 | 0.8188 | 2.10 | 1,944,706 | -1.37 | -61.36% |
3 Years | 10.04 | 29.40 | 0.8188 | 4.90 | 1,797,336 | -9.18 | -91.42% |
5 Years | 10.04 | 29.40 | 0.8188 | 4.90 | 1,797,336 | -9.18 | -91.42% |
Better Therapeutics Description
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. |